Invesco Ltd. Celldex Therapeutics, Inc. Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 62,886 shares of CLDX stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,886

Previous 52,443 19.91%

Holding current value

$1.74 Million

Previous $951,000 34.49%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$15.13 - $21.65 $158,002 - $226,090	10,443 Added 19.91%	62,886 $1.28 Million
Q1 2025 May 12, 2025	BUY	$18.15 - $27.6 $187,707 - $285,439	10,342 Added 24.56%	52,443 $951,000
Q4 2024 Feb 13, 2025	BUY	$23.31 - $32.4 $20,303 - $28,220	871 Added 2.11%	42,101 $1.06 Million
Q3 2024 Nov 12, 2024	BUY	$32.06 - $44.56 $3,109 - $4,322	97 Added 0.24%	41,230 $1.4 Million
Q2 2024 Aug 13, 2024	SELL	$32.76 - $42.56 $5.67 Million - $7.37 Million	-173,215 Reduced 80.81%	41,133 $1.52 Million
Q1 2024 May 14, 2024	SELL	$35.22 - $51.88 $1.52 Million - $2.24 Million	-43,215 Reduced 16.78%	214,348 $9 Million
Q4 2023 Feb 12, 2024	BUY	$22.61 - $40.65 $4.98 Million - $8.96 Million	220,428 Added 593.59%	257,563 $10.2 Million
Q3 2023 Nov 13, 2023	BUY	$25.45 - $37.46 $209,326 - $308,108	8,225 Added 28.45%	37,135 $1.02 Million
Q2 2023 Aug 11, 2023	SELL	$30.29 - $38.28 $2.01 Million - $2.54 Million	-66,246 Reduced 69.62%	28,910 $980,000
Q1 2023 May 12, 2023	BUY	$34.78 - $47.43 $649,481 - $885,707	18,674 Added 24.42%	95,156 $3.42 Million
Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $1.65 Million - $2.7 Million	59,505 Added 350.5%	76,482 $3.41 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $68,031 - $112,597	-2,997 Reduced 15.0%	16,977 $477,000
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $37,945 - $69,097	1,851 Added 10.21%	19,974 $539,000
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $5.24 Million - $7.45 Million	-189,549 Reduced 91.27%	18,123 $616,000
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $11.6 Million - $18.4 Million	-326,313 Reduced 61.11%	207,672 $8.03 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $3 Million - $5.8 Million	103,578 Added 24.07%	533,985 $28.8 Million
Q2 2021 Aug 17, 2021	BUY	$20.71 - $35.37 $3.52 Million - $6.01 Million	169,912 Added 65.23%	430,407 $14.4 Million
Q1 2021 May 17, 2021	BUY	$16.19 - $29.91 $4.22 Million - $7.79 Million	260,495 New	260,495 $5.37 Million
Q4 2020 Feb 16, 2021	SELL	$14.99 - $22.75 $8.01 Million - $12.2 Million	-534,584 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $5.16 Million - $8.12 Million	534,584 New	534,584 $7.93 Million
Q1 2020 May 15, 2020	SELL	$1.55 - $3.07 $61,060 - $120,939	-39,394 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.11 - $2.8 $5,492 - $7,288	-2,603 Reduced 6.2%	39,394 $88,000
Q3 2019 Nov 14, 2019	SELL	$2.05 - $2.75 $3,370 - $4,521	-1,644 Reduced 3.77%	41,997 $89,000
Q2 2019 Aug 14, 2019	SELL	$2.43 - $5.09 $3,662 - $7,670	-1,507 Reduced 3.34%	43,641 $117,000
Q1 2019 May 15, 2019	BUY	$3.45 - $10.35 $155,760 - $467,281	45,148 New	45,148 $222,000

Others Institutions Holding CLDX

# of Institutions

200

Shares Held

68.3M

Call Options Held

219K

Put Options Held

238K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.29B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account